caseism

Massachusetts General Hospital and the Enbrel Royalty Case Solution & Answer

Massachusetts General Hospital plans to sell its rights to Enbrel, Amgen’s blockbuster drug for the treatment of rheumatoid arthritis. To determine whether to sell and at what price, the hospital must determine its value to a potential buyer as well as its own value of royalty income.
by
David S. Scharfstein,
Darren R. Smart
Source: Harvard Business School
9 pages.
Date Posted: November 16, 2005. Prod #: 206075-PDF-ENG
Massachusetts General Hospital and the case of Enbrel solution file

Share This

LOOK FOR A FREE CASE STUDY SOLUTION

JUST REGISTER NOW AND GET 50% OFF ON EACH CASE STUDY